NEW YORK (GenomeWeb News) — Digilab BioVision today said it will offer GenWay Biotech’s Seppro IgY proteomics technology from its Hannover, Germany, facility.
 
Digilab said Seppro’s IgY technology selectively partitions the 12 most abundant proteins from human serum or plasma.
 
Digilab said its Peptidomics products and services increase the sensitivity and selectivity needed for drug-development proteomics.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genetic ancestry tested led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

In Science this week: approach to visualize chromatin structure in nuclei, and more.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.